Annual Net Income
-$105.37 M
+$631.00 K+0.60%
31 December 2023
Summary:
CymaBay Therapeutics annual net profit is currently -$105.37 million, with the most recent change of +$631.00 thousand (+0.60%) on 31 December 2023. During the last 3 years, it has fallen by -$15.37 million (-17.08%).CBAY Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$41.90 M
-$8.02 M-23.67%
31 December 2023
Summary:
CymaBay Therapeutics quarterly net profit is currently -$41.90 million, with the most recent change of -$8.02 million (-23.67%) on 31 December 2023.CBAY Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$105.37 M
-$15.27 M-16.95%
31 December 2023
Summary:
CymaBay Therapeutics TTM net profit is currently -$105.37 million, with the most recent change of -$15.27 million (-16.95%) on 31 December 2023.CBAY TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBAY Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -17.1% | -57.9% | -17.1% |
| 5 y5 years | -2.5% | -42.5% | -2.5% |
CBAY Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +946.1% | +5085.9% | +3909.5% |
CymaBay Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$105.37 M(-0.6%) | -$41.90 M(+23.7%) | -$105.37 M(+16.9%) |
| Sept 2023 | - | -$33.88 M(+4093.3%) | -$90.10 M(+11.6%) |
| June 2023 | - | -$808.00 K(-97.2%) | -$80.72 M(-24.6%) |
| Mar 2023 | - | -$28.78 M(+8.1%) | -$107.01 M(+1.0%) |
| Dec 2022 | -$106.00 M(+17.8%) | -$26.63 M(+8.7%) | -$106.00 M(+0.1%) |
| Sept 2022 | - | -$24.50 M(-9.6%) | -$105.91 M(+1.8%) |
| June 2022 | - | -$27.09 M(-2.4%) | -$104.09 M(+3.9%) |
| Mar 2022 | - | -$27.77 M(+4.6%) | -$100.22 M(+11.4%) |
| Dec 2021 | -$90.00 M(+76.5%) | -$26.54 M(+17.0%) | -$90.00 M(+13.6%) |
| Sept 2021 | - | -$22.68 M(-2.3%) | -$79.21 M(+16.6%) |
| June 2021 | - | -$23.22 M(+32.3%) | -$67.94 M(+22.5%) |
| Mar 2021 | - | -$17.55 M(+11.4%) | -$55.45 M(+8.8%) |
| Dec 2020 | -$50.99 M(-50.4%) | -$15.75 M(+37.9%) | -$50.99 M(-21.1%) |
| Sept 2020 | - | -$11.42 M(+6.5%) | -$64.65 M(-18.7%) |
| June 2020 | - | -$10.73 M(-18.0%) | -$79.51 M(-14.3%) |
| Mar 2020 | - | -$13.09 M(-55.5%) | -$92.82 M(-9.7%) |
| Dec 2019 | -$102.81 M(+41.7%) | -$29.41 M(+11.9%) | -$102.81 M(+10.7%) |
| Sept 2019 | - | -$26.28 M(+9.3%) | -$92.84 M(+9.1%) |
| June 2019 | - | -$24.04 M(+4.2%) | -$85.13 M(+8.3%) |
| Mar 2019 | - | -$23.07 M(+18.6%) | -$78.62 M(+8.4%) |
| Dec 2018 | -$72.55 M | -$19.45 M(+4.8%) | -$72.55 M(+24.8%) |
| Sept 2018 | - | -$18.56 M(+5.9%) | -$58.14 M(+21.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | -$17.53 M(+3.1%) | -$47.81 M(+21.9%) |
| Mar 2018 | - | -$17.00 M(+237.2%) | -$39.21 M(+42.3%) |
| Dec 2017 | -$27.56 M(+3.3%) | -$5.04 M(-38.8%) | -$27.56 M(-6.5%) |
| Sept 2017 | - | -$8.23 M(-7.8%) | -$29.47 M(+8.7%) |
| June 2017 | - | -$8.93 M(+66.9%) | -$27.11 M(+7.7%) |
| Mar 2017 | - | -$5.35 M(-23.0%) | -$25.17 M(-5.6%) |
| Dec 2016 | -$26.67 M(+71.7%) | -$6.95 M(+18.3%) | -$26.67 M(+3.8%) |
| Sept 2016 | - | -$5.88 M(-15.9%) | -$25.70 M(+0.1%) |
| June 2016 | - | -$6.99 M(+2.1%) | -$25.68 M(+28.1%) |
| Mar 2016 | - | -$6.85 M(+14.5%) | -$20.05 M(+29.1%) |
| Dec 2015 | -$15.53 M(-51.3%) | -$5.98 M(+1.9%) | -$15.53 M(-30.3%) |
| Sept 2015 | - | -$5.87 M(+332.2%) | -$22.27 M(-0.4%) |
| June 2015 | - | -$1.36 M(-41.7%) | -$22.37 M(-7.5%) |
| Mar 2015 | - | -$2.33 M(-81.7%) | -$24.18 M(-24.2%) |
| Dec 2014 | -$31.92 M(+216.9%) | -$12.72 M(+113.4%) | -$31.92 M(+38.1%) |
| Sept 2014 | - | -$5.96 M(+87.9%) | -$23.11 M(+25.2%) |
| June 2014 | - | -$3.17 M(-68.5%) | -$18.45 M(+5.4%) |
| Mar 2014 | - | -$10.06 M(+157.1%) | -$17.51 M(+73.8%) |
| Dec 2013 | -$10.07 M(-10.5%) | -$3.91 M(+199.5%) | -$10.07 M(+63.6%) |
| Sept 2013 | - | -$1.31 M(-41.2%) | -$6.16 M(+26.9%) |
| June 2013 | - | -$2.22 M(-15.4%) | -$4.85 M(+84.6%) |
| Mar 2013 | - | -$2.63 M | -$2.63 M |
| Dec 2012 | -$11.26 M | - | - |
FAQ
- What is CymaBay Therapeutics annual net profit?
- What is the all time high annual net income for CymaBay Therapeutics?
- What is CymaBay Therapeutics quarterly net profit?
- What is the all time high quarterly net income for CymaBay Therapeutics?
- What is CymaBay Therapeutics TTM net profit?
- What is the all time high TTM net income for CymaBay Therapeutics?
What is CymaBay Therapeutics annual net profit?
The current annual net income of CBAY is -$105.37 M
What is the all time high annual net income for CymaBay Therapeutics?
CymaBay Therapeutics all-time high annual net profit is -$10.07 M
What is CymaBay Therapeutics quarterly net profit?
The current quarterly net income of CBAY is -$41.90 M
What is the all time high quarterly net income for CymaBay Therapeutics?
CymaBay Therapeutics all-time high quarterly net profit is -$808.00 K
What is CymaBay Therapeutics TTM net profit?
The current TTM net income of CBAY is -$105.37 M
What is the all time high TTM net income for CymaBay Therapeutics?
CymaBay Therapeutics all-time high TTM net profit is -$2.63 M